|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/39541 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 31/4406 | (2013.01) | ||
| A61K 31/4406 | (2006.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/7068 | (2013.01) |
| (11) | Number of the document | 3600419 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18771465.4 |
| Date of filing the European patent application | 2018-03-14 | |
| (97) | Date of publication of the European application | 2020-02-05 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/022414 |
| Date | 2018-03-14 |
| (87) | Number | WO 2018/175179 |
| Date | 2018-09-27 |
| (30) | Number | Date | Country code |
| 201762473731 P | 2017-03-20 | US |
| (72) |
EVANS, Elizabeth , US
SMITH, Ernest S. , US
ZAUDERER, Maurice , US
|
| (73) |
Vaccinex, Inc. ,
1895 Mt. Hope Avenue, Rochester, NY 14620,
US
|
| (54) | TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENT |
| TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENT |